Handbook of Parkinson's Disease

5. Auflage 2013
ISBN: 978-1-84184-908-9
Verlag: CRC Press

Buch, Englisch, 620 Seiten, Format (B × H): 157 mm x 235 mm, Gewicht: 1036 g

Reihe: Neurological Disease and Therapy

Highly Commended, BMA Medical Book Awards 2014

This volume has long prevailed as one of the leading resources on Parkinson's disease (PD). Fully updated with practical and engaging chapters on pathology, neurochemistry, etiology, and breakthrough research, this source spans every essential topic related to the identification, assessment, and treatment of PD.

Reflecting the many advances that have taken place in the management of PD, this volume promotes a multidisciplinary approach to care and supplies new sections on the latest pharmacologic, surgical, and rehabilitative therapies, as well as essential diagnostic, imaging, and nonmotor management strategies.

New to this edition:

• Early identification of premotor symptoms

• Potential disease modification agents

• Physical and occupational therapy

Zielgruppe

Professional and Professional Practice & Development

Autoren/Hrsg.

Pahwa, Rajesh

Lyons Ph.D., Kelly E.

Fachgebiete

• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Klinische und Innere Medizin Neurologie, Klinische Neurowissenschaft

Inhaltsverzeichnis

Early Iconography of Parkinson’s Disease. Epidemiology. Differential Diagnosis. Pathophysiology and Clinical Assessment. Premotor Symptoms. Autonomic Dysfunction and Management. Sleep Dysfunction. Neuropsychological Aspects. Management of Anxiety and Depression. Management of Psychosis and Dementia. Neuroimaging. Neuropathology. Neurophysiology and Neurocircuitry. Animal Models. Genetics. Environmental Risk Factors. Disease Modification. Amantadine and Anticholinergics. Levodopa. Dopamine Agonists. MAO inhibitors. COMT Inhibitors. Investigational Pharmacological Treatments. Deep Brain Stimulation. Investigational Surgical Therapies. Physical and Occupational Therapy. Voice, Speech and Swallowing Disorders. Alternative Therapies.

Über Autor(innen)

Rajesh Pahwa MD is a clinician and Laverne and Joyce Rider Professor of Neurology and Director of the Parkinson's Disease and Movement Disorder Center, University of Kansas Medical Center.

Kelly E Lyons PhD is Director of Research and Education at the Parkinson's Disease and Movement Disorder Center, University of Kansas Medical Center.